Table 5.
Group |
Sample (n) |
Fibrosis phase |
Fibrotic area within 1.5 mm2(mm2) |
||||
---|---|---|---|---|---|---|---|
S0 | S1 | S2 | S3 | S4 | |||
Nomral |
7 |
7 |
0 |
0 |
0 |
0 |
0 |
Model |
7 |
0 |
0 |
2 |
4 |
1 |
0.090 ± 0.021△△ |
Silymarin |
7 |
0 |
2 |
3 |
2 |
0 |
0.067 ± 0.046 |
Berberine |
7 |
0 |
3 |
2 |
2 |
0 |
0.041 ± 0.020** |
CRAE |
7 |
0 |
2 |
3 |
2 |
0 |
0.056 ± 0.021* |
Bear Bile |
7 |
0 |
3 |
3 |
1 |
0 |
0.048 ± 0.046* |
TUDCA | 7 | 0 | 2 | 3 | 0 | 2 | 0.065 ± 0.047 |
△p < 0.05 when compared with normal group; △△p < 0.01 when compared with normal group; *p < 0.05 when compared with model group; **p < 0.01 when compared with model group.